- OraSure (OSUR +16.1%) is among the day's big winners after the company reported a Q2 loss that was narrower than analysts expected.
- Revenue growth of 8% for the period was attributable to strong sales of OSUR's "molecular collection systems and infectious disease testing products."
- OSUR guided for a Q3 net loss of $0.09-0.10/ share versus Street estimates of a $0.12 loss. Revenue guidance is in line with consensus. (PR)